Journal of Comprehensive Pediatrics

Published by: Kowsar

Validation of Aspartate Aminotransferase to Platelet Ratio for Diagnosis of Hepatic Fibrosis and Prognostic Prediction of Infants with Biliary Atresia after Portoenterostomy

Farid Imanzadeh 1 , Naghi Dara 1 , Pejman Rohani 1 , Batool Emadi 1 , Sara Sanii 2 , Mohadeseh Mousavi - Khorshidi 1 and Amir Hossein Hosseini 1 , *
Authors Information
1 Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Neonatal Health Research Center, Research Institute for Children Health, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Comprehensive Pediatrics: February 2018, 9 (1); e13304
  • Published Online: February 28, 2018
  • Article Type: Research Article
  • Received: May 14, 2017
  • Revised: August 19, 2017
  • Accepted: January 21, 2018
  • DOI: 10.5812/compreped.13304

To Cite: Imanzadeh F, Dara N, Rohani P, Emadi B, Sanii S, et al. Validation of Aspartate Aminotransferase to Platelet Ratio for Diagnosis of Hepatic Fibrosis and Prognostic Prediction of Infants with Biliary Atresia after Portoenterostomy, J Compr Ped. 2018 ;9(1):e13304. doi: 10.5812/compreped.13304.

Abstract
© 2018, Journal of Comprehensive Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Ohi R, Ibrahim M. Biliary atresia. Semin Pediatr Surg. 1992;1(2):115-24. [PubMed: 1345477].
  • 2. Vic P, Gestas P, Mallet EC, Arnaud JP. [Biliary atresia in French Polynesia. Retrospective study of 10 years]. Arch Pediatr. 1994;1(7):646-51. [PubMed: 7987462].
  • 3. Mieli-Vergani G, Vergani D. Biliary atresia. Semin Immunopathol. 2009;31(3):371-81. doi: 10.1007/s00281-009-0171-6. [PubMed: 19533128].
  • 4. Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148(4):467-74. doi: 10.1016/j.jpeds.2005.12.054. [PubMed: 16647406].
  • 5. Lai MW, Chang MH, Hsu SC, Hsu HC, Su CT, Kao CL, et al. Differential diagnosis of extrahepatic biliary atresia from neonatal hepatitis: a prospective study. J Pediatr Gastroenterol Nutr. 1994;18(2):121-7. [PubMed: 8014758].
  • 6. Pape L, Olsson K, Petersen C, von Wasilewski R, Melter M. Prognostic value of computerized quantification of liver fibrosis in children with biliary atresia. Liver Transpl. 2009;15(8):876-82. doi: 10.1002/lt.21711. [PubMed: 19642116].
  • 7. Dezsofi A, Baumann U, Dhawan A, Durmaz O, Fischler B, Hadzic N, et al. Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2015;60(3):408-20. doi: 10.1097/MPG.0000000000000632. [PubMed: 25383787].
  • 8. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30(6):1529-30. doi: 10.1002/hep.510300624. [PubMed: 10610352].
  • 9. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology. 2002;36(5 Suppl 1):S152-60. doi: 10.1053/jhep.2002.36381. [PubMed: 12407589].
  • 10. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344(7):495-500. doi: 10.1056/NEJM200102153440706. [PubMed: 11172192].
  • 11. Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology. 2008;134(6):1670-81. doi: 10.1053/j.gastro.2008.03.001. [PubMed: 18471546].
  • 12. Adler M, Gulbis B, Moreno C, Evrard S, Verset G, Golstein P, et al. The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases. Hepatology. 2008;47(2):762-3. author reply 763. doi: 10.1002/hep.22085. [PubMed: 18220307].
  • 13. Breton E, Bridoux-Henno L, Guyader D, Danielou H, Jouan H, Beuchee A, et al. [Value of transient elastography in noninvasive assessment in children's hepatic fibrosis]. Arch Pediatr. 2009;16(7):1005-10. doi: 10.1016/j.arcped.2009.03.021. [PubMed: 19446446].
  • 14. Yilmaz Y, Yonal O, Kurt R, Bayrak M, Aktas B, Ozdogan O. Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease. Hepat Mon. 2011;11(2):103-6. [PubMed: 22087126].
  • 15. Haafiz AB. Liver fibrosis in biliary atresia. Expert Rev Gastroenterol Hepatol. 2010;4(3):335-43. doi: 10.1586/egh.10.29. [PubMed: 20528120].
  • 16. Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D, Fard MK, et al. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. J Gastrointestin Liver Dis. 2010;19(2):169-74. [PubMed: 20593050].
  • 17. Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr. 2004;144(1):123-5. doi: 10.1016/j.jpeds.2003.09.042. [PubMed: 14722530].
  • 18. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-26. doi: 10.1053/jhep.2003.50346. [PubMed: 12883497].
  • 19. Snyder N, Gajula L, Xiao SY, Grady J, Luxon B, Lau DT, et al. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol. 2006;40(6):535-42. [PubMed: 16825937].
  • 20. Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Intern Med. 2008;47(7):569-75. [PubMed: 18379139].
  • 21. Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis. 2008;40(4):267-74. doi: 10.1016/j.dld.2007.10.011. [PubMed: 18055281].
  • 22. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343-50. [PubMed: 15685546].
  • 23. Lakshminarayanan B, Davenport M. Biliary atresia: A comprehensive review. J Autoimmun. 2016;73:1-9. doi: 10.1016/j.jaut.2016.06.005. [PubMed: 27346637].
  • 24. Foroutan HR, Hosseini AH, Dehghani SM, Banani SA, Bahador A, Haghighat M, et al. Peri-operative high-dose v post-operative low dose steroid therapy in the management of biliary atresia: A preliminary report. Iran J Med Sci. 2008;33(2):79-83.
  • 25. Khosravi A, Anbardar MH, Forootan HR, Imanieh MH, Noorafshan A, Geramizadeh B, et al. Comparison of the Stereological Study Findings of Liver Biopsy Between Biliary Atresia and Neonatal Hepatitis: Is It Helpful in Differentiating Them? Shiraz E-Med J. 2014;15(1).
  • 26. Denton A, Davis P. Extreme thrombocytosis in admissions to paediatric intensive care: no requirement for treatment. Arch Dis Child. 2007;92(6):515-6. doi: 10.1136/adc.2006.111484. [PubMed: 17515621].
  • 27. Kim SY, Seok JY, Han SJ, Koh H. Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia. J Pediatr Gastroenterol Nutr. 2010;51(2):198-202. doi: 10.1097/MPG.0b013e3181da1d98. [PubMed: 20531020].
  • 28. Yang LY, Fu J, Peng XF, Pang SY, Gao KK, Chen ZR, et al. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia. World J Gastroenterol. 2015;21(19):5893-900. doi: 10.3748/wjg.v21.i19.5893. [PubMed: 26019453].
  • 29. Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, Manesis EK, et al. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Eur J Gastroenterol Hepatol. 2006;18(4):389-96. [PubMed: 16538110].
  • 30. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005;42(2):282-92. doi: 10.1002/hep.20772. [PubMed: 15986415].
  • 31. Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, et al. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol. 2007;22(11):1904-8. doi: 10.1111/j.1440-1746.2006.04628.x. [PubMed: 17914968].
  • 32. Shin NY, Kim MJ, Lee MJ, Han SJ, Koh H, Namgung R, et al. Transient elastography and sonography for prediction of liver fibrosis in infants with biliary atresia. J Ultrasound Med. 2014;33(5):853-64. doi: 10.7863/ultra.33.5.853. [PubMed: 24764341].

Altmetric:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Comments